CVS Health Corporation (CVS)
56.47 USD -1.28 (-2.22%) Volume: 9.14M
CVS Health Corporation’s stock price is currently at 56.47 USD, experiencing a decrease of -2.22% this trading session with a trading volume of 9.14M. With a year-to-date percentage change of -28.48%, investors are closely monitoring the performance of CVS stocks.
Latest developments on CVS Health Corporation
Despite a recent drop in stock price for CVS Health Corp (NYSE:CVS), concerns within the industry continue to linger. This comes as Simply Better Brands Corp. announces the nationwide rollout of their TRUBAR™ product in 6,600 CVS pharmacies. Additionally, SFE Investment Counsel has sold shares in CVS Health Co. These events have contributed to fluctuations in the stock price of CVS Health Corp today.
CVS Health Corporation on Smartkarma
Analysts at Baptista Research on Smartkarma have been closely monitoring the performance of Cvs Health Corp. In their report titled “CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations! – Major Drivers,” the analysts highlighted the company’s mixed financial results in the second quarter of 2024. Despite facing notable challenges, CVS Health reported an adjusted earnings per share of $1.83 and revenues exceeding $91 billion, supported by strong performance in the Health Services and Pharmacy & Consumer Wellness segments.
Another report by Baptista Research titled “CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last? – Major Drivers,” discussed the Q1 2024 earnings of CVS Health. The analysts noted both positive and negative impacts on the company’s business structure, with lower-than-expected earnings per share of $1.31. The Medicare Advantage segment faced significant utilization pressures, leading to a revision of full-year guidance for adjusted EPS to at least $7. Despite these challenges, analysts remain optimistic about the strategic leverage of CVS Health in the pharmacy benefit management and insurance operations.
A look at CVS Health Corporation Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, CVS Health Corp has a positive long-term outlook. With a top score in both Value and Dividend, the company is seen as a strong investment opportunity for those looking for stable returns. While its Growth and Resilience scores are slightly lower, the company still maintains a solid overall outlook. Additionally, CVS Health Corp has a Momentum score of 4, indicating a positive trend in the company’s performance.
CVS Health Corporation is an integrated pharmacy health care provider that offers a range of services including pharmacy benefit management, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. Operating drugstores across the U.S., the District of Columbia, and Puerto Rico, CVS Health Corp is a well-established player in the healthcare industry with a focus on providing accessible and convenient healthcare services to its customers.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
